Irminix (emeramide)
/ EmeraMed
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 26, 2021
EMERA007: Phase 2a Pilot Study of NBMI Treatment in Patients With Beta Thalassemia Major, Requiring Iron Chelation
(clinicaltrials.gov)
- P2a; N=13; Completed; Sponsor: EmeraMed; Recruiting ➔ Completed
Clinical • Trial completion • Beta-Thalassemia • Genetic Disorders • MRI
March 04, 2021
"Emeramide for Mercury Toxicity 🤞"
(@alfonsopereze)
1 to 2
Of
2
Go to page
1